0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover0.00%IV456.79%PremiumSep 20, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Applied DNA Sciences Stock Discussion
Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit
Applied DNA Sciences (NASDAQ:APDN) announced its participation in the 3rd Annual mRNA Process Development & Manufacturing Summit in Boston from September 17-19, 2024. The company will showcase its Linea™ IVT platform, a solution for faster and better mRNA production with reduced double-stra...
Applied DNA Launches Mpox Clade I and Clade II Testing Service
Applied DNA Sciences (NASDAQ:APDN) has announced the expansion of its clinical testing services for Mpox (formerly monkeypox) to include both Clade I and Clade II detection. This launch follows interactions with regulatory bodies, including the New York State Department of Health (NYSDOH) and the FDA. The company's subsidiary, Applied DNA Clinical Labs (ADCL), will provide the testing service from ...
hi
No comment yet